News & Updates
Filter by Specialty:
HRT use tied to reduced COVID-19 death risk
The use of hormonal replacement therapy (HRT) among postmenopausal women may be associated with a reduced risk of mortality after a COVID-19 diagnosis, according to a retrospective study from Sweden.
HRT use tied to reduced COVID-19 death risk
02 Jun 2022
Novel biomarkers predict immunotherapy response, side effects in HCC
A team of Singapore-based researchers has identified two blood biomarkers that not only predict clinical response to immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC) patients but also the incidence of side effects from the same treatment.
Novel biomarkers predict immunotherapy response, side effects in HCC
02 Jun 2022
Multivitamins help improve colorectal cancer survival
Patients who take multivitamin supplements at a moderate dose following their diagnosis of nonmetastatic colorectal cancer (CRC) appear to have a lower mortality, reports a recent study.
Multivitamins help improve colorectal cancer survival
02 Jun 2022
Whole pelvic radiation therapy improves survival in high-risk prostate cancer
Prostate cancer (PCa) patients with higher lymph node (LN) risk scores and Gleason grade who are treated with whole pelvis radiotherapy (WPRT) have better overall survival (OS), reports a study.
Whole pelvic radiation therapy improves survival in high-risk prostate cancer
02 Jun 2022
Accelerated daratumumab infusion safe, well tolerated in multiple myeloma
Accelerated administration of daratumumab, an anti-CD3 monoclonal antibody approved for multiple myeloma, is safe and well tolerated when given following at least two standard infusions, suggest the results of a recent study.